Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: Population based case-control study

BMJ (Online)

Volumn 346, Issue 7907, 2013, Pages

  Rai, Dheeraj ^a,b,c   Lee, Brian K ^d   Dalman, Christina ^b   Golding, Jean ^a   Lewis, Glyn ^a   Magnusson, Cecilia ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b KAROLINSKA INSTITUTE   (Sweden)

^c AVON AND WILTSHIRE MENTAL HEALTH PARTNERSHIP NHS TRUST   (United Kingdom)

^d DREXEL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; AUTISM; CHILD; CHILDBIRTH; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DRUG USE; FEMALE; HIGH RISK POPULATION; HUMAN; INFANT; INTELLECTUAL IMPAIRMENT; INTERVIEW; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRENATAL DRUG EXPOSURE; PRENATAL PERIOD; PRIORITY JOURNAL; PROGENY; PROSPECTIVE STUDY; REGISTER; RISK ASSESSMENT; SWEDEN;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; CASE-CONTROL STUDIES; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; COHORT STUDIES; DEPRESSIVE DISORDER; FEMALE; HUMANS; INFANT; INTELLECTUAL DISABILITY; MALE; MIDDLE AGED; PARENTS; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; SWEDEN; YOUNG ADULT;

EID: 84878304990     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f2059     Document Type: Article

References (46)

1. Prevalence of autism spectrum disorders-Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ 2012;61:1-19.
2. Idring S, Rai D, Dal H, Dalman C, Sturm H, Zander E et al. Autism spectrum disorders in the Stockholm Youth Cohort: design, prevalence and validity. PloS one 2012;7:e41280.
3. Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T, et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 2011;68:1095-102.
4. Croen LA, Grether JK, Yoshida CK, Odouli R, Hendrick V. Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch Gen Psychiatry 2011;68:1104-12.
5. Levitt P. Serotonin and the autisms: a red flag or a red herring? Arch Gen Psychiatry 2011;68:1093-4.
6. Daniels JL, Forssen U, Hultman CM, Cnattingius S, Savitz DA, Feychting M, et al. Parental psychiatric disorders associated with autism spectrum disorders in the offspring. Pediatrics 2008;121:e1357-62.
7. Gardener H, Spiegelman D, Buka SL. Prenatal risk factors for autism: comprehensive meta-analysis. Br J Psychiatry 2009;195:7-14.
8. Yirmiya N, Shaked M. Psychiatric disorders in parents of children with autism: a meta-analysis. J Child Psychol Psychiatry 2005;46:69-83. (Pubitemid 40220796)
9. Magnusson C, Rai D, Goodman A, Lundberg M, Idring S, Svensson A, et al. Migration and autism spectrum disorder: population-based study. Br J Psychiatry 2012;201:109-15.
10. Rai D, Lewis G, Lundberg M, Araya R, Svensson A, Dalman C, et al. Parental socioeconomic status and risk of offspring autism spectrum disorders in a Swedish population-based study. J Am Acad Child Adolesc Psychiatry 2012;51:467-76.
11. Axén M. ADHD, lindrig utvecklingsstörning och autismspektrumtillstånd hos barn, ungdomar och vuxna [ADHD, mild mental retardation and autism spectrum disorders in children, adolescents and adults]. Stockholms läns landsting, 2010.
12. Jorgensen L, Ahlbom A, Allebeck P, Dalman C. The Stockholm non-affective psychoses study (snaps): the importance of including out-patient data in incidence studies. Acta Psychiatr Scand 2010;121:389-92.
13. Quality of data and reporting procedures in the National Patient Register. Discharges from inpatient care 1964-2007 and visits to specialiced outpatient care (excluding primary health care) 1997-2007 [In Swedish]. National Board of Health and Welfare, 2009.
14. World Health Organization. The ICD-10 classification of mental and behavioural disorders diagnostic criteria for research. WHO, 1993.
15. Axelsson O. The Swedish medical birth register. Acta Obstet Gynecol Scand 2003;82:491-2. (Pubitemid 36750699)
16. Kallen B, Nilsson E, Olausson PO. Antidepressant use during pregnancy: comparison of data obtained from a prescription register and from antenatal care records. Eur J Clin Pharmacol 2011;67:839-45.
17. Stephansson O, Granath F, Svensson T, Haglund B, Ekbom A, Kieler H. Drug use during pregnancy in Sweden-assessed by the Prescribed Drug Register and the Medical Birth Register. Clin Epidemiol 2011;3:43-50.
18. Kolevzon A, Gross R, Reichenberg A. Prenatal and perinatal risk factors for autism: a review and integration of findings. Arch Pediatr Adolesc Med 2007;161:326-33. (Pubitemid 46556362)
19. Abel KM, Dalman C, Svensson A, Susser E, Dal H, Idring S, et al. Deviance in fetal growth and risk of autism spectrum disorder. Am J Psychiatry 2013;170:391-8.
20. Lee BK, Gardner RM, Dal H, Svensson A, Galanti MR, Rai D, et al. Brief report: maternal smoking during pregnancy and autism spectrum disorders. J Autism Dev Disord 2012;42:2000-5.
21. Gardener H, Spiegelman D, Buka SL. Perinatal and neonatal risk factors for autism: a comprehensive meta-analysis. Pediatrics 2011;128:344-55.
22. El Marroun H, Jaddoe VW, Hudziak JJ, Roza SJ, Steegers EA, Hofman A, et al. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. Arch Gen Psychiatry 2012;69:706-14.
23. Schisterman EF, Cole SR, Platt RW. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology 2009;20:488-95.
24. Jokiranta E, Brown AS, Heinimaa M, Cheslack-Postava K, Suominen A, Sourander A. Parental psychiatric disorders and autism spectrum disorders. Psychiatry Res 2013; published online 4 Feb.
25. Lauritsen MB, Pedersen CB, Mortensen PB. Effects of familial risk factors and place of birth on the risk of autism: a nationwide register-based study. J Child Psychol Psychiatry 2005;46:963-71. (Pubitemid 44192664)
26. Larsson HJ, Eaton WW, Madsen KM, Vestergaard M, Olesen AV, Agerbo E, et al. Risk factors for autism: perinatal factors, parental psychiatric history, and socioeconomic status. Am J Epidemiol 2005;161:916-25. (Pubitemid 40656413)
27. Zafeiriou DI, Ververi A, Vargiami E. The serotonergic system: its role in pathogenesis and early developmental treatment of autism. Curr Neuropharmacol 2009;7:150-7.
28. Chadman KK. Fluoxetine but not risperidone increases sociability in the BTBR mouse model of autism. Pharmacol Biochem Behav 2011;97:586-94.
29. Darling RD, Alzghoul L, Zhang JL, Khatri N, Paul IA, Simpson KL, et al. Perinatal citalopram exposure selectively increases locus ceruleus circuit function in male rats. J Neurosci 2011;31:16709-15.
30. Rodriguez-Porcel F, Green D, Khatri N, Harris SS, May WL, Lin RCS, et al. Neonatal exposure of rats to antidepressants affects behavioral reactions to novelty and social interactions in a manner analogous to autistic spectrum disorders. Anat Rec (Hoboken) 2011;294:1726-35.
31. Simpson KL, Weaver KJ, de Villers-Sidani E, Lu JYF, Cai ZW, Pang Y, et al. Perinatal antidepressant exposure alters cortical network function in rodents. Proc Natl Acad Sci USA 2011;108:18465-70.
32. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med 2005;352:1112-20.
33. Kinney DK, Munir KM, Crowley DJ, Miller AM. Prenatal stress and risk for autism. Neurosci Biobehav Rev 2008;32:1519-32.
34. Rai D, Golding J, Magnusson C, Steer C, Lewis G, Dalman C. Prenatal and early life exposure to stressful life events and risk of autism spectrum disorders: population-based studies in sweden and England. PloS One 2012;7:e38893.
35. Maes M. Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:664-75.
36. Onore C, Careaga M, Ashwood P. The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun 2012;26:383-92.
37. Delong GR. Autism: new data suggest a new hypothesis. Neurology 1999;52:911-6.
38. Greenland S. The effect of misclassification in the presence of covariates. Am J Epidemiol 1980;112:564-9. (Pubitemid 10029558)
39. Ogburn EL, VanderWeele TJ. On the nondifferential misclassification of a binary confounder. Epidemiology 2012;23:433-9.
40. Stewart DE. Clinical practice. Depression during pregnancy. N Engl J Med 2011;365:1605-11.
41. Spinelli M. Antidepressant treatment during pregnancy. Am J Psychiatry 2012;169:121-4.
42. Rahimi R, Nikfar S, Abdollahi M. Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials. Reprod Toxicol 2006;22:571-5. (Pubitemid 44592550)
43. Lund N, Pedersen LH, Henriksen TB. Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes. Arch Pediatr Adolesc Med 2009;163:949-54.
44. Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry 2006;63:898-906. (Pubitemid 44188483)
45. Reis M, Kallen B. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med 2010;40:1723-33.
46. Occhiogrosso M, Omran SS, Altemus M. Persistent pulmonary hypertension of the newborn and selective serotonin reuptake inhibitors: lessons from clinical and translational studies. Am J Psychiatry 2012;169:134-40.